Evaluating the Role of Biomarkers for Evaluating Treatment Response & Disease Progression in Neuroinflammatory Disorders
Time: 9:30 am
day: Conference Day Two
Details:
- Dissecting biomarkers of acute inflammatory versus chronic insidious injury in Multiple Sclerosis
- Evaluating the direct and indirect impacts of a high-efficacy disease modifying treatment
- Identifying proof-of-activity biomarkers correlating with clinical outcomes and their implications for drug development
